; and (2) the Subcommittees on Defense of the Committees on Appropriations of the House of Representatives and the Senate. 813. Report on the pharmaceutical and personal protective equipment regulatory practices of the People’s Republic of China (a) Report Not later than 120 days after the date of the enactment of this Act, the Director of National Intelligence shall submit to the appropriate congressional committees, and make publicly available on the internet website of the Director, a report on the pharmaceutical and personal protective equipment regulatory practices of the People’s Republic of China. (b) Contents The report under subsection (a) shall include the following: (1) An assessment of the quantity of active pharmaceutical ingredients produced annually within China. (2) An estimate of the percentage of active pharmaceutical ingredients produced globally that originate in China. (3) A description of the National Medical Products Administration of China, including with respect to— (A) the roles and responsibilities of the Administration; (B) the organizational structure of the Administration